zolpidem has been researched along with caffeine in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (8.70) | 18.2507 |
| 2000's | 12 (52.17) | 29.6817 |
| 2010's | 8 (34.78) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Goldman, NH; Madakasira, S; Rowlett, JK; Rush, CR; Woolverton, WL | 1 |
| Mattila, MJ; Nurminen, ML; Vainio, P; Vanakoski, J | 1 |
| Baker, RW; Rowlett, JK; Rush, CR | 1 |
| Bickel, WK; Smith, BJ | 1 |
| Batéjat, D; Beaumont, M; Coste, O; Lagarde, D; Piérard, C; Van Beers, P | 1 |
| Hutson, PH; Ivarsson, M; Nutt, DJ; Paterson, LM; Wilson, SJ | 3 |
| Cysneiros, RM; Farkas, D; Greenblatt, DJ; Harmatz, JS; von Moltke, LL | 1 |
| Myslobodsky, M | 1 |
| Fisher, SP; Foster, RG; Godinho, SI; Hankins, MW; Peirson, SN; Pothecary, CA | 1 |
| Cho, S; Kim, D; Kim, SB; Kwon, S; Lee, J; Moon, KD; Yoon, M | 1 |
| Anilanmert, B; Caglar-Andac, S; Narin, I | 1 |
2 review(s) available for zolpidem and caffeine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The paradox of caffeine-zolpidem interaction: a network analysis.
Topics: Animals; Antioxidants; Caffeine; Central Nervous System Stimulants; Drug Synergism; Humans; Hypnotics and Sedatives; Melatonin; Pyridines; Reactive Oxygen Species; Software; Zolpidem | 2009 |
7 trial(s) available for zolpidem and caffeine
| Article | Year |
|---|---|
Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.
Topics: Adult; Caffeine; Discrimination Learning; Dose-Response Relationship, Drug; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Pentobarbital; Pyridines; Triazolam; Zolpidem | 1997 |
Zolpidem 10 mg given at daytime is not antagonized by 300 mg caffeine in man.
Topics: Adult; Caffeine; Central Nervous System Stimulants; Circadian Rhythm; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Female; Humans; Hypnotics and Sedatives; Male; Placebos; Pyridines; Zolpidem | 1998 |
Discriminative-stimulus effects of zolpidem, triazolam, pentobarbital, and caffeine in zolpidem-trained humans.
Topics: Adult; Caffeine; Central Nervous System Stimulants; Cues; Discrimination Learning; Discrimination, Psychological; Female; Humans; Hypnotics and Sedatives; Male; Mental Recall; Pentobarbital; Psychomotor Performance; Pyridines; Surveys and Questionnaires; Triazolam; Zolpidem | 2000 |
Prior sleep with zolpidem enhances the effect of caffeine or modafinil during 18 hours continuous work.
Topics: Adult; Aerospace Medicine; Attention; Benzhydryl Compounds; Caffeine; Central Nervous System Stimulants; Delayed-Action Preparations; Double-Blind Method; Electroencephalography; Fatigue; Humans; Hypnotics and Sedatives; Male; Memory; Military Medicine; Modafinil; Pyridines; Reaction Time; Sleep; Wakefulness; Work; Zolpidem | 2006 |
A translational, caffeine-induced model of onset insomnia in rats and healthy volunteers.
Topics: Adult; Animals; Caffeine; Central Nervous System Stimulants; Cross-Over Studies; Disease Models, Animal; Dose-Response Relationship, Drug; Double-Blind Method; Electroencephalography; Electromyography; GABA Agonists; Humans; Hypnotics and Sedatives; Male; Polysomnography; Pyridines; Rats; Rats, Sprague-Dawley; Reference Values; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Initiation and Maintenance Disorders; Telemetry; Trazodone; Zolpidem | 2007 |
Pharmacokinetic and pharmacodynamic interactions between zolpidem and caffeine.
Topics: Administration, Oral; Adult; Caffeine; Central Nervous System Stimulants; Cognition; Cross-Over Studies; Double-Blind Method; Drug Interactions; Electroencephalography; Female; Humans; Hypnotics and Sedatives; Male; Mental Recall; Pyridines; Reaction Time; Sleep; Zolpidem | 2007 |
Effects on sleep stages and microarchitecture of caffeine and its combination with zolpidem or trazodone in healthy volunteers.
Topics: Adult; Caffeine; Central Nervous System Stimulants; Cross-Over Studies; Double-Blind Method; Electroencephalography; Humans; Hypnotics and Sedatives; Male; Polysomnography; Pyridines; Sleep Initiation and Maintenance Disorders; Sleep Stages; Trazodone; Young Adult; Zolpidem | 2009 |
14 other study(ies) available for zolpidem and caffeine
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Effects of alprazolam, caffeine, and zolpidem in humans trained to discriminate triazolam from placebo.
Topics: Adolescent; Adult; Alprazolam; Analysis of Variance; Caffeine; Discrimination, Psychological; Female; GABA Agonists; GABA Modulators; Humans; Male; Phosphodiesterase Inhibitors; Pyridines; Triazolam; Zolpidem | 2001 |
Characterisation of the effects of caffeine on sleep in the rat: a potential model of sleep disruption.
Topics: Animals; Body Temperature; Caffeine; Central Nervous System Stimulants; Disease Models, Animal; Electroencephalography; Electromyography; Hypnotics and Sedatives; Male; Motor Activity; Pyridines; Rats; Rats, Sprague-Dawley; Sleep; Sleep Initiation and Maintenance Disorders; Telemetry; Trazodone; Zolpidem | 2009 |
Rapid assessment of sleep-wake behavior in mice.
Topics: Animals; Automation, Laboratory; Behavior, Animal; Caffeine; Electroencephalography; Electromyography; Light; Male; Mice; Mice, Inbred C57BL; Monitoring, Physiologic; Pyridines; Sleep; Video Recording; Wakefulness; Zolpidem | 2012 |
A Standardized Phlorotannin Supplement Attenuates Caffeine-Induced Sleep Disruption in Mice.
Topics: Animals; Caffeine; Electroencephalography; Electromyography; Follow-Up Studies; Hypnotics and Sedatives; Mice; Phytotherapy; Plant Preparations; Polyphenols; Receptors, GABA-A; Seaweed; Sleep; Sleep Aids, Pharmaceutical; Sleep Initiation and Maintenance Disorders; Zolpidem | 2019 |
Urgent first-step screening method for ketamine, phenobarbital, zopiclone, zolpidem, phenytoin and thiopental in adulterated soft drink.
Topics: Caffeine; Carbonated Beverages; Female; Humans; Ketamine; Phenobarbital; Phenytoin; Reproducibility of Results; Thiopental; Zolpidem | 2023 |